B

Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613

Watchlist Manager
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Watchlist
Price: 8.47 HKD 0.59%
Market Cap: 7.1B HKD
Have any thoughts about
Beijing Tong Ren Tang Chinese Medicine Co Ltd?
Write Note

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Long-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
B
Beijing Tong Ren Tang Chinese Medicine Co Ltd
HKEX:3613
Long-Term Debt
HK$78m
CAGR 3-Years
1%
CAGR 5-Years
3%
CAGR 10-Years
N/A
G
Grand Pharmaceutical Group Ltd
HKEX:512
Long-Term Debt
HK$2.1B
CAGR 3-Years
5%
CAGR 5-Years
28%
CAGR 10-Years
27%
U
United Laboratories International Holdings Ltd
HKEX:3933
Long-Term Debt
ÂĄ1.4B
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
-2%
Sino Biopharmaceutical Ltd
HKEX:1177
Long-Term Debt
ÂĄ1.2B
CAGR 3-Years
-54%
CAGR 5-Years
-14%
CAGR 10-Years
1%
C
China Resources Pharmaceutical Group Ltd
HKEX:3320
Long-Term Debt
HK$21.7B
CAGR 3-Years
58%
CAGR 5-Years
11%
CAGR 10-Years
N/A
H
HUTCHMED (China) Ltd
HKEX:13
Long-Term Debt
$55.6m
CAGR 3-Years
111%
CAGR 5-Years
72%
CAGR 10-Years
8%
No Stocks Found

Beijing Tong Ren Tang Chinese Medicine Co Ltd
Glance View

Market Cap
7.1B HKD
Industry
Pharmaceuticals

Beijing Tong Ren Tang Chinese Medicine Co., Ltd. engages in the manufacture, retail and wholesale of Chinese medicine and healthcare products. The company employs 745 full-time employees The company went IPO on 2013-05-07. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. The company is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

Intrinsic Value
11.88 HKD
Undervaluation 29%
Intrinsic Value
Price
B

See Also

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Long-Term Debt?
Long-Term Debt
78m HKD

Based on the financial report for Jun 30, 2024, Beijing Tong Ren Tang Chinese Medicine Co Ltd's Long-Term Debt amounts to 78m HKD.

What is Beijing Tong Ren Tang Chinese Medicine Co Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 5Y
3%

Over the last year, the Long-Term Debt growth was 2%. The average annual Long-Term Debt growth rates for Beijing Tong Ren Tang Chinese Medicine Co Ltd have been 1% over the past three years , 3% over the past five years .

Back to Top